Veterinary Medicine Information website

CORIPRAVAC ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Authorised
  • Avibacterium paragallinarum, serotype C, strain Modesto, Inactivated
  • Avibacterium paragallinarum, serotype B, strain 0222, Inactivated
  • Avibacterium paragallinarum, serotype A, strain 17756, Inactivated
Download as PDF

Product identification

Medicine name:
CORIPRAVAC ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Avibacterium paragallinarum, serotype C, strain Modesto, Inactivated
  • Avibacterium paragallinarum, serotype B, strain 0222, Inactivated
  • Avibacterium paragallinarum, serotype A, strain 17756, Inactivated
Target species:
  • Poultry
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Avibacterium paragallinarum, serotype C, strain Modesto, Inactivated
    200000000.00
    Organisms
    /
    0.50
    millilitre(s)
  • Avibacterium paragallinarum, serotype B, strain 0222, Inactivated
    200000000.00
    Organisms
    /
    0.50
    millilitre(s)
  • Avibacterium paragallinarum, serotype A, strain 17756, Inactivated
    200000000.00
    Organisms
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Poultry
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 31179/21-10-2003/K-0074701
Date of authorisation status change: